© The International Congress on Controversies in Stem Cell and Cellular Therapies (COSTEM).

Contact:
Tel: +44 20 3289 9552

Treating NHL and MM in the age of CAR T

Celgene supported Industry Symposium – (Hall A)

Friday, October 25

08:00–09:00

Chair: Nicolaus Kröger, Hamburg
08:00–08:20
The science behind CAR T: What can we expect?
Michael Hudecek, Würzburg
08:20–08:40
CAR T for patients with aggressive NHL and CLL: an emerging treatment option
Marion Subklewe, Munich
08:40–09:00
Harnessing the immune system with BCMA targeting CAR T cells in Multiple Myeloma
Michael Hudecek
, Würzburg